Breaking News

Yesterday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Options
Largest borrow rate increases among liquid names » 08:45
08/06/20
08/06
08:45
08/06/20
08:45
BLDP

Ballard Power

$15.16 /

+0.14 (+0.93%)

, DGLY

Digital Ally

$3.30 /

-0.05 (-1.49%)

, LMND

Lemonade

$64.46 /

+3.32 (+5.43%)

, MNK

Mallinckrodt

$1.54 /

-0.08 (-4.94%)

, JNUG

Direxion Daily Jr Gld Mnrs Bull 3X Shrs

$180.04 /

+4.14 (+2.35%)

, XRX

Xerox

$16.12 /

+0.44 (+2.81%)

, AMC

AMC Entertainment

$4.14 /

+0.04 (+0.98%)

, EOLS

Evolus

$3.29 /

+0.15 (+4.78%)

, GAN

Gan Limited

$20.26 /

+0.51 (+2.58%)

, SKYY

OmniSky Corp

$79.51 /

-0.18 (-0.23%)

Latest data shows the…

Latest data shows the largest indicative borrow rate increases among liquid option names include: Ballard Power (BLDP) 17.02% +6.17, Digital Ally (DGLY) 53.54% +3.93, Lemonade (LMND) 5.13% +2.20, Mallinckrodt (MNK) 37.31% +1.34, Direxion Junior Gold (JNUG) 3.76% +0.95, Xerox (XRX) 0.50% +0.25, AMC Entertainment (AMC) 79.51% +0.24, Evolus (EOLS) 32.85% +0.20, GAN Ltd (GAN) 1.30% +0.19, and First Trust ISE Cloud Computing Index Fund (SKYY) 0.84% +0.16.

ShowHide Related Items >><<
XRX Xerox
$16.12 /

+0.44 (+2.81%)

MNK Mallinckrodt
$1.54 /

-0.08 (-4.94%)

LMND Lemonade
$64.46 /

+3.32 (+5.43%)

JNUG Direxion Daily Jr Gld Mnrs Bull 3X Shrs
$180.04 /

+4.14 (+2.35%)

GAN Gan Limited
$20.26 /

+0.51 (+2.58%)

EOLS Evolus
$3.29 /

+0.15 (+4.78%)

DGLY Digital Ally
$3.30 /

-0.05 (-1.49%)

BLDP Ballard Power
$15.16 /

+0.14 (+0.93%)

AMC AMC Entertainment
$4.14 /

+0.04 (+0.98%)

BLDP Ballard Power
$15.16 /

+0.14 (+0.93%)

07/13/20 Roth Capital
Ballard Power price target raised to $25 from $20 at Roth Capital
07/06/20 National Bank
Ballard Power initiated with a Sector Perform at National Bank
06/29/20 Roth Capital
Ballard Power upgraded to Buy at Roth Capital
06/29/20 Roth Capital
Ballard Power upgraded to Buy from Neutral at Roth Capital
DGLY Digital Ally
$3.30 /

-0.05 (-1.49%)

06/29/20 Aegis
Digital Ally initiated with a Buy at Aegis
LMND Lemonade
$64.46 /

+3.32 (+5.43%)

07/27/20
Fly Intel: Top five analyst initiations
07/27/20 Oppenheimer
Lemonade initiated with a Perform at Oppenheimer
07/27/20 Goldman Sachs
Lemonade initiated with a Sell at Goldman Sachs
07/27/20 Barclays
Lemonade initiated with an Equal Weight at Barclays
MNK Mallinckrodt
$1.54 /

-0.08 (-4.94%)

08/06/20 Citi
Mallinckrodt price target lowered to $1 from $2 at Citi
08/05/20 BMO Capital
Mallinckrodt price target lowered to $2 from $4 at BMO Capital
08/04/20 Piper Sandler
Mallinckrodt downgraded to Underweight from Neutral at Piper Sandler
07/14/20 BMO Capital
Briefing docs suggest AdComm 'challenges' for Mallinckrodt, says BMO Capital
JNUG Direxion Daily Jr Gld Mnrs Bull 3X Shrs
$180.04 /

+4.14 (+2.35%)

XRX Xerox
$16.12 /

+0.44 (+2.81%)

07/24/20
Fly Intel: Top five analyst downgrades
07/24/20 JPMorgan
JPMorgan downgrades Xerox to Underweight, sees long recovery
07/24/20 JPMorgan
Xerox downgraded to Underweight from Neutral at JPMorgan
04/27/20 Loop Capital
Xerox, Park City, NetApp, HP Enterprise cut to Hold from Buy at Loop Capital
AMC AMC Entertainment
$4.14 /

+0.04 (+0.98%)

07/13/20 MKM Partners
MKM Partners lowers price targets in Cinema sector
06/30/20 Imperial Capital
AMC Entertainment price target lowered to $4 from $6 at Imperial Capital
06/29/20 Credit Suisse
Cinemark downgraded to Neutral from Outperform at Credit Suisse
06/29/20 Credit Suisse
AMC Entertainment downgraded to Underperform from Neutral at Credit Suisse
EOLS Evolus
$3.29 /

+0.15 (+4.78%)

07/07/20 Truist
Evolus price target lowered to $6 from $12 at SunTrust
07/07/20 Mizuho
Evolus downgraded to Neutral from Buy at Mizuho
07/07/20 H.C. Wainwright
Evolus price target lowered to $7 from $15 at H.C. Wainwright
06/02/20 Mizuho
Evolus fundamentals unchanged despite ITC delay, says Mizuho
GAN Gan Limited
$20.26 /

+0.51 (+2.58%)

07/17/20 Northland
Gan Limited initiated with an Outperform at Northland
07/14/20 Craig-Hallum
NJ sports betting up despite no sports, iGaming also strong, says Craig-Hallum
06/18/20 Craig-Hallum
Gan Limited price target raised to $28 from $25 at Craig-Hallum
06/18/20 B. Riley FBR
Gan Limited price target raised to $28.50 from $24 at B. Riley FBR
SKYY OmniSky Corp
$79.51 /

-0.18 (-0.23%)

XRX Xerox
$16.12 /

+0.44 (+2.81%)

MNK Mallinckrodt
$1.54 /

-0.08 (-4.94%)

GAN Gan Limited
$20.26 /

+0.51 (+2.58%)

EOLS Evolus
$3.29 /

+0.15 (+4.78%)

DGLY Digital Ally
$3.30 /

-0.05 (-1.49%)

BLDP Ballard Power
$15.16 /

+0.14 (+0.93%)

AMC AMC Entertainment
$4.14 /

+0.04 (+0.98%)

  • 02
    Jul
  • 08
    Jun
  • 02
    Jun
  • 05
    May
  • 28
    Feb
  • 07
    Nov
XRX Xerox
$16.12 /

+0.44 (+2.81%)

MNK Mallinckrodt
$1.54 /

-0.08 (-4.94%)

GAN Gan Limited
$20.26 /

+0.51 (+2.58%)

DGLY Digital Ally
$3.30 /

-0.05 (-1.49%)

BLDP Ballard Power
$15.16 /

+0.14 (+0.93%)

AMC AMC Entertainment
$4.14 /

+0.04 (+0.98%)

XRX Xerox
$16.12 /

+0.44 (+2.81%)

MNK Mallinckrodt
$1.54 /

-0.08 (-4.94%)

LMND Lemonade
$64.46 /

+3.32 (+5.43%)

EOLS Evolus
$3.29 /

+0.15 (+4.78%)

DGLY Digital Ally
$3.30 /

-0.05 (-1.49%)

AMC AMC Entertainment
$4.14 /

+0.04 (+0.98%)

XRX Xerox
$16.12 /

+0.44 (+2.81%)

MNK Mallinckrodt
$1.54 /

-0.08 (-4.94%)

LMND Lemonade
$64.46 /

+3.32 (+5.43%)

JNUG Direxion Daily Jr Gld Mnrs Bull 3X Shrs
$180.04 /

+4.14 (+2.35%)

GAN Gan Limited
$20.26 /

+0.51 (+2.58%)

EOLS Evolus
$3.29 /

+0.15 (+4.78%)

DGLY Digital Ally
$3.30 /

-0.05 (-1.49%)

BLDP Ballard Power
$15.16 /

+0.14 (+0.93%)

AMC AMC Entertainment
$4.14 /

+0.04 (+0.98%)

SKYY OmniSky Corp
$79.51 /

-0.18 (-0.23%)

Over a week ago
Initiation
Fly Intel: Top five analyst initiations » 10:17
07/27/20
07/27
10:17
07/27/20
10:17
IMTX

Immatics

$11.00 /

+0.5 (+4.76%)

, STSA

Satsuma Pharmaceuticals

$26.44 /

+0.94 (+3.69%)

, OSK

Oshkosh

$79.89 /

+1.435 (+1.83%)

, LMND

Lemonade

$71.74 /

-6.32 (-8.10%)

, ACCD

Accolade

$33.05 /

+0.08 (+0.24%)

Catch up on today's…

Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Immatics (IMTX) initiated with an Outperform at SVB Leerink. 2. Satsuma Pharmaceuticals (STSA) initiated with a Buy at H.C. Wainwright. 3. Oshkosh (OSK) initiated with an Outperform at Raymond James. 4. Lemonade (LMND) was initiated with an Outperform at JMP Securities, a Market Perform at William Blair, a Perform at Oppenheimer, an Equal Weight at Barclays and Morgan Stanley, and a Sell at Goldman Sachs. 5. Accolade (ACCD) initiated with a Buy at Goldman Sachs and BofA, an Overweight at Morgan Stanley and Piper Sandler, a Market Perform at SVB Leerinkm, and a Neutral at Credit Suisse. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.

ShowHide Related Items >><<
STSA Satsuma Pharmaceuticals
$26.44 /

+0.94 (+3.69%)

OSK Oshkosh
$79.89 /

+1.435 (+1.83%)

LMND Lemonade
$71.74 /

-6.32 (-8.10%)

IMTX Immatics
$11.00 /

+0.5 (+4.76%)

IMTX Immatics
$11.00 /

+0.5 (+4.76%)

07/27/20 SVB Leerink
SVB Leerink bullish on Immatics, initiates with an Outperform
07/27/20 SVB Leerink
Immatics initiated with an Outperform at SVB Leerink
07/24/20
Fly Intel: Top five analyst initiations
07/24/20 Jefferies
Jefferies starts Immatics at Buy with $14 price target
STSA Satsuma Pharmaceuticals
$26.44 /

+0.94 (+3.69%)

07/27/20 H.C. Wainwright
Satsuma Pharmaceuticals initiated with a Buy at H.C. Wainwright
03/11/20 SVB Leerink
Satsuma Pharmaceuticals price target raised to $35 from $20 at SVB Leerink
03/02/20 Credit Suisse
Satsuma Pharmaceuticals price target raised to $32 from $20 at Credit Suisse
02/05/20 Mizuho
Satsuma Pharmaceuticals initiated with a Buy at Mizuho
OSK Oshkosh
$79.89 /

+1.435 (+1.83%)

07/27/20 Raymond James
Oshkosh initiated with an Outperform at Raymond James
07/27/20 Raymond James
Oshkosh initiated with an Outperform at Raymond James
07/01/20 Deutsche Bank
Oshkosh resumed with a Buy at Deutsche Bank
06/04/20
Fly Intel: Top five analyst upgrades
LMND Lemonade
$71.74 /

-6.32 (-8.10%)

07/27/20 Oppenheimer
Lemonade initiated with a Perform at Oppenheimer
07/27/20 Goldman Sachs
Lemonade initiated with a Sell at Goldman Sachs
07/27/20 Barclays
Lemonade initiated with an Equal Weight at Barclays
07/27/20 JMP Securities
Lemonade initiated with an Outperform at JMP Securities
ACCD Accolade
$33.05 /

+0.08 (+0.24%)

07/27/20 SVB Leerink
Accolade initiated with a Market Perform at SVB Leerink
07/27/20 BofA
Accolade initiated with a Buy at BofA
07/27/20 Morgan Stanley
Accolade initiated with an Overweight at Morgan Stanley
07/27/20 BofA
Accolade initiated with a Buy at BofA
STSA Satsuma Pharmaceuticals
$26.44 /

+0.94 (+3.69%)

OSK Oshkosh
$79.89 /

+1.435 (+1.83%)

  • 02
    Jul
  • 02
    Jul
  • 13
    Sep
OSK Oshkosh
$79.89 /

+1.435 (+1.83%)

LMND Lemonade
$71.74 /

-6.32 (-8.10%)

LMND Lemonade
$71.74 /

-6.32 (-8.10%)

On The Fly
Fly Intel: Pre-market Movers » 08:56
07/27/20
07/27
08:56
07/27/20
08:56
MRNA

Moderna

$73.20 /

-2.17 (-2.88%)

, MNOV

MediciNova

$5.68 /

-0.045 (-0.79%)

, SAP

SAP

$158.73 /

-2.47 (-1.53%)

, AVY

Avery Dennison

$120.38 /

-0.505 (-0.42%)

, RPM

RPM

$79.68 /

+1.565 (+2.00%)

, HAS

Hasbro

$77.60 /

-2.18 (-2.73%)

, UA

Under Armour

$9.82 /

+0.035 (+0.36%)

, EMAN

eMagin

$1.30 /

+0.42 (+47.73%)

, LMND

Lemonade

$78.06 /

-3.98 (-4.85%)

, UAA

Under Armour

$10.91 /

+0.03 (+0.28%)

Check out this morning's…

Open Full Text

ShowHide Related Items >><<
UAA Under Armour
$10.91 /

+0.03 (+0.28%)

UA Under Armour
$9.82 /

+0.035 (+0.36%)

SAP SAP
$158.73 /

-2.47 (-1.53%)

RPM RPM
$79.68 /

+1.565 (+2.00%)

MRNA Moderna
$73.20 /

-2.17 (-2.88%)

MNOV MediciNova
$5.68 /

-0.045 (-0.79%)

LMND Lemonade
$78.06 /

-3.98 (-4.85%)

HAS Hasbro
$77.60 /

-2.18 (-2.73%)

EMAN eMagin
$1.30 /

+0.42 (+47.73%)

AVY Avery Dennison
$120.38 /

-0.505 (-0.42%)

MRNA Moderna
$73.20 /

-2.17 (-2.88%)

07/24/20 Baird
Arbutus Biopharma upside priced in, Baird downgrades to Neutral
07/23/20 SVB Leerink
Moderna initiated with a Market Perform at SVB Leerink
07/20/20 Jefferies
AstraZeneca slide 'overdone' after 'encouraging' vaccine data, says Jefferies
07/20/20
Fly Intel: Top five analyst downgrades
MNOV MediciNova
$5.68 /

-0.045 (-0.79%)

SAP SAP
$158.73 /

-2.47 (-1.53%)

07/20/20 Morgan Stanley
SAP price target raised to EUR 148 from EUR 114 at Morgan Stanley
07/10/20 Barclays
SAP price target raised to EUR 158 from EUR 120 at Barclays
07/10/20 Deutsche Bank
SAP price target raised to EUR 144 from EUR 120 at Deutsche Bank
07/10/20 Argus
SAP price target raised to $175 from $145 at Argus
AVY Avery Dennison
$120.38 /

-0.505 (-0.42%)

06/10/20 Baird
Avery Dennison price target raised to $130 from $120 at Baird
06/01/20 Atlantic Equities
Avery Dennison initiated with an Overweight at Atlantic Equities
03/25/20 BMO Capital
Avery Dennison price target lowered to $127 from $151 at BMO Capital
03/20/20 Loop Capital
Avery Dennison upgraded to Buy from Hold at Loop Capital
RPM RPM
$79.68 /

+1.565 (+2.00%)

05/29/20 JPMorgan
Axalta Coating price target raised to $27 from $22 at JPMorgan
04/09/20 BMO Capital
RPM price target lowered to $80 from $90 at BMO Capital
03/26/20 Wells Fargo
RPM price target lowered to $71 from $84 at Wells Fargo
03/26/20 RBC Capital
RPM upgraded to Outperform from Sector Perform at RBC Capital
HAS Hasbro
$77.60 /

-2.18 (-2.73%)

06/09/20
Fly Intel: Top five analyst downgrades
06/09/20 Consumer Edge
Hasbro downgraded to Equal Weight from Overweight at Consumer Edge
06/03/20 Argus
Hasbro price target lowered to $90 from $100 at Argus
05/04/20 Barclays
Hasbro price target lowered to $95 from $112 at Barclays
UA Under Armour
$9.82 /

+0.035 (+0.36%)

07/23/20 Jefferies
Jefferies 'wouldn't chase' Nike shares near all-time highs
07/10/20 Morgan Stanley
Under Armour appears to be taking 'prudent look' at costs, says Morgan Stanley
05/12/20 Barclays
Under Armour price target lowered to $9 from $10 at Barclays
05/08/20 Citi
Under Armour price target lowered to $15 from $17 at Citi
EMAN eMagin
$1.30 /

+0.42 (+47.73%)

08/14/19
eMagin downgraded to Hold at Craig-Hallum
08/13/19 Craig-Hallum
eMagin downgraded to Hold from Buy at Craig-Hallum
LMND Lemonade
$78.06 /

-3.98 (-4.85%)

07/27/20 Oppenheimer
Lemonade initiated with a Perform at Oppenheimer
07/27/20 Goldman Sachs
Lemonade initiated with a Sell at Goldman Sachs
07/27/20 Barclays
Lemonade initiated with an Equal Weight at Barclays
07/27/20 JMP Securities
Lemonade initiated with an Outperform at JMP Securities
UAA Under Armour
$10.91 /

+0.03 (+0.28%)

07/24/20 Deutsche Bank
Under Armour named short-term buy idea at Deutsche Bank
07/21/20 BTIG
BTIG sees signs of distress at Under Armour, keeps $5 price target
UAA Under Armour
$10.91 /

+0.03 (+0.28%)

UA Under Armour
$9.82 /

+0.035 (+0.36%)

SAP SAP
$158.73 /

-2.47 (-1.53%)

RPM RPM
$79.68 /

+1.565 (+2.00%)

MRNA Moderna
$73.20 /

-2.17 (-2.88%)

HAS Hasbro
$77.60 /

-2.18 (-2.73%)

AVY Avery Dennison
$120.38 /

-0.505 (-0.42%)

  • 02
    Jul
  • 19
    May
  • 12
    Feb
  • 06
    Nov
UA Under Armour
$9.82 /

+0.035 (+0.36%)

SAP SAP
$158.73 /

-2.47 (-1.53%)

MRNA Moderna
$73.20 /

-2.17 (-2.88%)

HAS Hasbro
$77.60 /

-2.18 (-2.73%)

UA Under Armour
$9.82 /

+0.035 (+0.36%)

SAP SAP
$158.73 /

-2.47 (-1.53%)

RPM RPM
$79.68 /

+1.565 (+2.00%)

MRNA Moderna
$73.20 /

-2.17 (-2.88%)

LMND Lemonade
$78.06 /

-3.98 (-4.85%)

HAS Hasbro
$77.60 /

-2.18 (-2.73%)

UAA Under Armour
$10.91 /

+0.03 (+0.28%)

UA Under Armour
$9.82 /

+0.035 (+0.36%)

MRNA Moderna
$73.20 /

-2.17 (-2.88%)

LMND Lemonade
$78.06 /

-3.98 (-4.85%)

HAS Hasbro
$77.60 /

-2.18 (-2.73%)

EMAN eMagin
$1.30 /

+0.42 (+47.73%)

Initiation
Lemonade initiated with a Perform at Oppenheimer » 07:33
07/27/20
07/27
07:33
07/27/20
07:33
LMND

Lemonade

$78.06 /

-3.98 (-4.85%)

Oppenheimer analyst Jason…

Oppenheimer analyst Jason Helfstein initiated coverage of Lemonade with a Perform rating, citing valuation. The analyst notes that as a leader in the digitization of insurance, the company is leveraging deep data capabilities through machine learning, paired with a contemporary designed customer user experience to appeal to Millennial and Gen Z customers and grow with them as insurance needs expand with personal wealth levels. Moreover, Proportional Reinsurance model effectively insulates gross margin versus typical insurance models more susceptible to volatility., he contends. While forecasting a 66% adjusted gross profit growth annually 2020-2025, Helfstein believes shares are fully valued at 41-times 2022 EV/GP, a 258% premium to peers, even with growth about 270% faster.

ShowHide Related Items >><<
LMND Lemonade
$78.06 /

-3.98 (-4.85%)

LMND Lemonade
$78.06 /

-3.98 (-4.85%)

07/27/20 Goldman Sachs
Lemonade initiated with a Sell at Goldman Sachs
07/27/20 Barclays
Lemonade initiated with an Equal Weight at Barclays
07/27/20 JMP Securities
Lemonade initiated with an Outperform at JMP Securities
07/27/20 Morgan Stanley
Lemonade initiated with an Equal Weight at Morgan Stanley
  • 02
    Jul
LMND Lemonade
$78.06 /

-3.98 (-4.85%)

LMND Lemonade
$78.06 /

-3.98 (-4.85%)

Initiation
Lemonade initiated with a Sell at Goldman Sachs » 07:06
07/27/20
07/27
07:06
07/27/20
07:06
LMND

Lemonade

$78.06 /

-3.98 (-4.85%)

Goldman Sachs analyst…

Goldman Sachs analyst Heath Terry initiated coverage of Lemonade with a Sell rating and $44 price target. With the shares trading at 27 times estimated 2022 enterprise value to GAAP revenue or 48 times estimated enterprise value to adjusted gross profit, the risks outweigh potential rewards, Terry tells investors in a research note. The analyst says with an "earlier than normal" lockup expiration, better entry points should arise as both the company and its float grows. Terry sees a "higher risk profile" as Lemonade works to transition its reinsurance relationships, significantly lower its net loss ratio, and expand its product offering into more competitive categories, like homeowners and pet insurance.

ShowHide Related Items >><<
LMND Lemonade
$78.06 /

-3.98 (-4.85%)

LMND Lemonade
$78.06 /

-3.98 (-4.85%)

07/27/20 Barclays
Lemonade initiated with an Equal Weight at Barclays
07/27/20 JMP Securities
Lemonade initiated with an Outperform at JMP Securities
07/27/20 Morgan Stanley
Lemonade initiated with an Equal Weight at Morgan Stanley
07/27/20 William Blair
Lemonade initiated with a Market Perform at William Blair
  • 02
    Jul
LMND Lemonade
$78.06 /

-3.98 (-4.85%)

LMND Lemonade
$78.06 /

-3.98 (-4.85%)

Initiation
Lemonade initiated with an Equal Weight at Barclays » 06:30
07/27/20
07/27
06:30
07/27/20
06:30
LMND

Lemonade

$78.06 /

-3.98 (-4.85%)

Barclays analyst Ross…

Barclays analyst Ross Sandler initiated coverage of Lemonade with an Equal Weight rating and $83 price target. The analyst is "very bullish" on the company's longer term opportunity but looks to accumulate the shares as the "euphoria around the story fades a bit."

ShowHide Related Items >><<
LMND Lemonade
$78.06 /

-3.98 (-4.85%)

LMND Lemonade
$78.06 /

-3.98 (-4.85%)

07/27/20 JMP Securities
Lemonade initiated with an Outperform at JMP Securities
07/27/20 Morgan Stanley
Lemonade initiated with an Equal Weight at Morgan Stanley
07/27/20 William Blair
Lemonade initiated with a Market Perform at William Blair
  • 02
    Jul
LMND Lemonade
$78.06 /

-3.98 (-4.85%)

LMND Lemonade
$78.06 /

-3.98 (-4.85%)

Initiation
Lemonade initiated with an Outperform at JMP Securities » 06:26
07/27/20
07/27
06:26
07/27/20
06:26
LMND

Lemonade

$78.06 /

-3.98 (-4.85%)

JMP Securities analyst…

JMP Securities analyst Ronald Josey initiated coverage of Lemonade with an Outperform rating and $105 price target. The company's DTC self-serve, "tech-first" approach to selling insurance and targeting new-to-insurance customers mainly through renters coverage while "graduating customers" with growing life insurance needs is helping it to take market share in the $4T consumer-focused insurance industry, the analyst tells investors in a research note.

ShowHide Related Items >><<
LMND Lemonade
$78.06 /

-3.98 (-4.85%)

LMND Lemonade
$78.06 /

-3.98 (-4.85%)

07/27/20 Morgan Stanley
Lemonade initiated with an Equal Weight at Morgan Stanley
07/27/20 William Blair
Lemonade initiated with a Market Perform at William Blair
  • 02
    Jul
LMND Lemonade
$78.06 /

-3.98 (-4.85%)

LMND Lemonade
$78.06 /

-3.98 (-4.85%)

Initiation
Lemonade initiated with an Equal Weight at Morgan Stanley » 06:13
07/27/20
07/27
06:13
07/27/20
06:13
LMND

Lemonade

$78.06 /

-3.98 (-4.85%)

Morgan Stanley analyst…

Morgan Stanley analyst Michael Phillips initiated coverage of Lemonade with an Equal Weight rating and $91 price target. Lemonade's differentiated model is a "welcome" disrupter in the fragmented homeowners market, and direct to consumer should allow for continued strong growth, Phillips tells investors in a research note. While the analyst sees 60% gross written premium CAGR in the near-term and 30% over 10 years, Phillips believes this growth is already priced in.

ShowHide Related Items >><<
LMND Lemonade
$78.06 /

-3.98 (-4.85%)

LMND Lemonade
$78.06 /

-3.98 (-4.85%)

07/27/20 William Blair
Lemonade initiated with a Market Perform at William Blair
  • 02
    Jul
LMND Lemonade
$78.06 /

-3.98 (-4.85%)

LMND Lemonade
$78.06 /

-3.98 (-4.85%)

Initiation
Lemonade initiated with a Market Perform at William Blair » 04:51
07/27/20
07/27
04:51
07/27/20
04:51
LMND

Lemonade

$78.06 /

-3.98 (-4.85%)

William Blair analyst…

William Blair analyst Ralph Schackart initiated coverage of Lemonade with a Market Perform rating and no price target. The analyst views the company's digital-only model as "compelling" but prefers to wait for a better entry point for the shares.

ShowHide Related Items >><<
LMND Lemonade
$78.06 /

-3.98 (-4.85%)

  • 02
    Jul
LMND Lemonade
$78.06 /

-3.98 (-4.85%)

LMND Lemonade
$78.06 /

-3.98 (-4.85%)

Hot Stocks
Lemonade CEO: COVID-19 has not had a major impact on our business » 18:41
07/23/20
07/23
18:41
07/23/20
18:41
LMND

Lemonade

$82.04 /

+3.6 (+4.59%)

In an interview on…

In an interview on CNBC's Mad Money, Daniel Schreiber said insurance may be the most disruptable industry on the planet. We saw that the industry was plagued by distrust. Things that were viewed as assets are now starting to look like liabilities, he noted. The core elements of our business have continued to thrive through the COVID-19 pandemic, Schreiber said.

ShowHide Related Items >><<
LMND Lemonade
$82.04 /

+3.6 (+4.59%)

  • 02
    Jul
LMND Lemonade
$82.04 /

+3.6 (+4.59%)

LMND Lemonade
$82.04 /

+3.6 (+4.59%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.